Harrow (HROW) Operating Income (2010 - 2026)
Harrow (HROW) posted quarterly Operating Income of -$22.1 million for Q1 2026, down 96.58% year-over-year from -$645.8 million in Q1 2025, and down 241.62% quarter-over-quarter from $15.6 million in Q4 2025.
Harrow (HROW) Operating Income (2010 - 2026) Analysis & Trends
Harrow's Operating Income history runs 17 years deep, the most recent figure standing at -$22.1 million for Q1 2026.
- In Q1 2026, Operating Income fell 96.58% year-over-year to -$22.1 million; the TTM figure through Mar 2026 stood at $19.7 million (up 335.3% YoY), while the FY2025 annual figure was $30.5 million, up 245.9% from the prior year.
- Operating Income for Q1 2026 stood at -$22.1 million, down from $15.6 million in the prior quarter.
- The five-year high for Operating Income was $15.6 million in Q4 2025, with the low at -$22.1 million in Q1 2026.
- The 5-year median for Operating Income is $1.5 million (2024), against an average of $1.2 million.
- The sharpest annual moves came in 2023 and 2024: Operating Income jumped 1955.32% in 2023, then sank 672.56% in 2024.
- Harrow's Operating Income stood at -$1.8 million in 2022, then plunged by 174.18% to -$4.9 million in 2023, then jumped by 364.59% to $12.9 million in 2024, then grew by 20.87% to $15.6 million in 2025, then slumped by 241.62% to -$22.1 million in 2026.
- Business Quant data shows HROW's Operating Income at -$22.1 million in Q1 2026, $15.6 million in Q4 2025, and $14.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Harrow | 1.57 Bn | 1.49 Bn | 50.36 Mn | -11.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.01 Mn |
| Mar 31, 2026 | -22.08 Mn |
| Dec 31, 2025 | 15.59 Mn |
| Sep 30, 2025 | 14.75 Mn |
| Jun 30, 2025 | 11.41 Mn |
| Mar 31, 2025 | -11.23 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | -6.93 Mn |
| Dec 31, 2023 | -4.88 Mn |
| Sep 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 2.35 Mn |
| Mar 31, 2023 | 1.21 Mn |
| Dec 31, 2022 | -1.78 Mn |
| Sep 30, 2022 | -94,000.00 |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 2.10 Mn |
| Dec 31, 2021 | -1.76 Mn |
| Sep 30, 2021 | -3.72 Mn |